Linoleic acid (LA)

Linoleic acid is an **essential omega-6 polyunsaturated fatty acid** (PUFA) with the formula C₁₈H₃₂O₂, featuring double bonds at the 9 and 12 positions[2][7][10]. It is the predominant dietary omega-6 fatty acid, found in high quantities in vegetable oils such as safflower, sunflower, and corn oil. Linoleic acid is required for human health because it cannot be synthesized endogenously: it maintains cell membrane structure and fluidity, serves as the precursor for longer-chain omega-6 fatty acids (notably arachidonic acid), and gives rise to numerous bioactive lipids, including eicosanoids (prostaglandins, leukotrienes, thromboxanes) and oxidized linoleic acid metabolites (OXLAMs)[3][5][6]. Physiologically, linoleic acid is incorporated into cell membranes and can be enzymatically converted to arachidonic acid, which is central to inflammatory signaling and a modulator of immune responses[3][5][6]. Metabolism of linoleic acid by cytochrome P450, cyclooxygenase, and lipoxygenase enzymes generates active metabolites that influence inflammation, pain sensation, cardiovascular function, and other processes. Dietary linoleic acid intake is generally associated with favorable cardiovascular outcomes, though its inflammatory potential is debated depending on metabolic context and omega-6/omega-3 ratios[6][9]. Linoleic acid's role is as an essential nutrient and biochemical precursor, **not as a classical therapeutic target**[2][3][7]. It does not have directly interacting approved drugs, but modulation of its metabolic pathways (e.g., inhibition of soluble epoxide hydrolase to alter downstream metabolites) has been investigated for therapeutic potential in conditions such as metabolic syndrome and cardiovascular disease[5]. Excessive or imbalanced intake may contribute to increased inflammation, oxidative stress, or cardiovascular risks, particularly if not balanced with omega-3 fatty acids[3][6][9].

Other names

cis,cis-9,12-octadecadienoic acid18:2(n-6)18:2Δ9,12LA

Not directly drug-targeted; its metabolites are modulated by enzyme inhibitors (e.g., soluble epoxide hydrolase inhibitors)[5]